ArticleEuropean journal of endocrinology2022

18-year change in serum intact fibroblast growth factor 23 from midlife to late life and risk of mortality: the ARIC Study.

Junichi Ishigami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.